Skip to content
TwitterYoutubeLinkedin

(678) 384-7220

info@geovax.com

GeoVax, Inc.
  • Search

  • About GeoVax
    • Company
    • Leadership
    • Board of Directors & Corporate Advisors
    • Scientific Advisory Board
  • Technology
    • Gedeptin® Technology Overview
    • MVA Technology Overview
    • Publications
  • Pipeline
    • Pipeline Summary
    • Infectious Diseases
    • Oncology
  • Investors
    • Corporate Profile
    • Press Releases
    • Media
    • Events & Presentations
    • SEC Filings
    • GeoVax Stock Information
    • Corporate Governance
    • Analyst Coverage
    • Investor FAQs
  • Careers
  • Contact us

Investor FAQs

Frequently Asked Questions

GeoVax Labs, Inc. is incorporated in Delaware.

GeoVax headquarters is located at 1955 Lake Park Drive, Suite 300, Atlanta, Georgia 30080.

Womble Bond Dickinson (US) LLP
1331 Spring Street, NW
Suite 1400
Atlanta, Georgia 30309
(404) 872-7000 tel
(404) 888-7490 fax

Porter Keadle Moore LLP
235 Peachtree Street, NE, Suite 1800
Atlanta, Georgia 30303
(404) 588-4200 tel
(404) 588-4222 fax

GeoVax’s fiscal year-end is December 31st. Reporting quarters correspond with calendar quarters.

GeoVax Labs, Inc. is listed on the Nasdaq-CM under the ticker symbol GOVX.

Stock may be purchased through any registered broker. GeoVax does not have a Direct Stock Purchase Plan at this time.

The CUSIP number for our Common Stock (GOVX) is 373678705.

Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
(800) 937-5449 / (718) 921-8124 tel

General Communications for Shareholders:

EQ
PO Box 500
Newark, NJ 07101
helpAST@equiniti.com

Contact Equiniti Trust Company, LLC (“EQ”) who can look up your records and make any necessary adjustments. There may be a fee involved for replacing lost stock certificates.

For the most current investor and company news from GeoVax email your contact information to investor@geovax.com.

SUBSCRIBE FOR UPDATES FROM GEOVAX

Register to receive email alerts for GeoVax press releases












About GeoVax

  • Company
  • Board of Directors & Corporate Advisors
  • Scientific Advisory Board

Our Technology

  • Gedeptin® Technology Overview
  • MVA Technology Overview
  • Publications

Product Pipeline

    • Pipeline Summary
    • Infectious Diseases
    • Oncology

 

Investors

    • Corporate Profile
    • Events & Presentations
    • GeoVax Stock Information
    • Corporate Governance

 

GeoVax © 2026 All Rights Reserved.

Biotech Web Design and Hosting